Brevetti EPO No.2931752 2019.08.14
Brevetti EPO
(10) Registration Number and Date
2019000623 2019.11.14
Status
Expired
(180) Expiration Date
(20) Filing Number and Date
SM /T/2019/000623 2013.12.17
(40) Publication Number and Date
SM /T/2019/000623 2019.11.14
(30) Priority Details
US 201261738008 P
2012.12.17
(51) IPC Classes
(71/73) Applicant
(IT) TRILLIUM THERAPEUTICS INC. : 2488 Dunwin Drive, Mississauga, Ontario L5L 1J9, CA
(72) Inventor
(IT) PANG, Xinli : 190 Mountainash Road, Brampton, ON L6R 3H1, CA
(IT) UGER, Robert Adam : 20 Reditt Court, Richmond Hill, ON L4C 7S4, CA
(IT) SLAVOVA-PETROVA, Penka Slavtcheva : 1207-2261 Lake Shore Blvd West, Toronto, ON M8V 3X1, CA
(74) Representative Name
(IT) CATALDI, Silvia : Via Consiglio dei Sessanta, 99, 47891 Dogana RSM, SM
(54) Title
(IT) TRATTAMENTO DI CELLULE DI MALATTIA CD47+ CON FUSIONI SIRP ALPHA-FC
(EN) TREATMENT OF CD47+ DISEASE CELLS WITH SIRP ALPHA-FC FUSIONS
(57) Abstract
(58) Citations
Document Type Date Action
Traduzione 2020.01.20
Event NameDateStatus
Filing2013.12.17Filed
Brevetto EPO concesso2019.11.14Published
Ricevuta pagamento annualita 72019.12.20Payed
Ricevuta pagamento annualita 82020.12.30Payed
Ricevuta pagamento annualita 92021.12.23Payed
Decaduto per non pagamento tassa2023.08.23Expired